Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2015-01-05 18:43:36
Reporting Period:
Filing Date:
Accepted Time:
2015-01-05 18:43:36
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
907562 Dyax Corp DYAX Services-Commercial Physical & Biological Research (8731) 043053198
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1226283 A Burt Adelman C/o Dyax Corp.
55 Network Drive
Burlington MA 01803-2756
Cmo & Evp, R&d No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-01-02 75,000 $1.48 112,500 No 4 M Direct
Common Stock Disposition 2015-01-02 75,000 $14.05 37,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2015-01-02 75,000 $0.00 75,000 $1.48
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
220,000 2022-02-24 No 4 M Direct
  1. The sales reported in this form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 4, 2014.
  2. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $13.82 to $14.38, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within that range.
  3. Such option vests in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, which was February 24, 2012.